Board of Directors

The Board of Directors is responsible for Genovis’ long-term operations and the organization of the company.

Genovis’ Board consists of four members elected by the AGM. The Board meets five times a year according to the schedule adopted by the Board. In addition to regular meetings, the Board may also be convened as necessary.

Member of the Board of Directors since: 2020
Born: 1952
Education: B.Sc. in Economics, CBS
Shares in Genovis: 100,000 shares

Other Directorship

Torben Jørgensen is Chairman of the Board of Biotage AB and Atlas Antibodies AB. He also serves on the boards of Boule Diagnostics, Medistim AS and Advanced Instruments.

Relevant Work Experience

Previous appointments include CEO and President of Biotage AB, Affibody AB, Karo Bio and DAKO A/S.

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: October 18, 2021

Member of the board since: 2014
Born: 1949
Education: MD
Shares in Genovis: Holds 9,990,653 shares

Other Directorship

Board member of Dentalum Operations AB, PRIMA Barn- och Vuxenpsykiatri Holding AB, PRIMA Barn AB, Dicel AB, Redeye AB/Redhold AB, Vasa Angels AB, Mikael Lönn AB, Professionell ägarstyrning i Sverige AB, Professionell ägarstyrning PÄAB ll, Skogsägarna Mellanskog Ekonomisk förening and Wingspan Company Culture AB.

Relevant Work Experience

Mikael Lönn is a physician, entrepreneur and has been active as business leader, mainly in the health care sector. He has extensive experience of financial investments, providing consultancy services and participated on the board of directors for a number of startup and growth companies, as well as experience from large county council and municipal-owned organi­zations.

Independency: Independent in relation to the company’s management and its major shareholders but not in relation to the company.

Last updated: February 15, 2022


Member of the board since: 2019
Born: 1961
Education: PhD Biochemistry
Shares in Genovis: 5,160 shares

Other Directorship

Lotta Ljungqvist is Chairman of the board of Directors of SwedenBio and she also serves on the boards of Atlas Antibodies AB, BioArctic AB, Arocell AB, Vinnova and chairman of IVA Avd X Bioteknik.

Relevant Work Experience

Currently employed as CEO of Testa Center in Uppsala. She is the former CEO of GE Nordics, IMED AB and global head of BioProcess R&D GE Healthcare Life Sciences. She has also held several project management positions at Biovitrum, Pharmacia Corp and Pharmacia & Upjohn.

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: March 23, 2022


Member of the board since: 2021
Born: 1953
Education: CChem FRSC
Shares in Genovis: None

Other Directorship

Steve Jordan has no other board assignments.

Relevant Work Experience

Steve is currently working as a consultant for several companies engaged in the development of novel technologies and materials for the life science industries. Prior experience includes Chief Scientific Officer and Senior Director R&D Chemistry at Biotage, Head of Business Development at CombiPure UK, Director of Analytical Sciences, Compound Management and Instrument Development at Millennium UK and Section Leader for High Throughput Medicinal Chemistry at Roche Discovery Welwyn.

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: Mar 23, 2022

Member of the board since: 2022
Born: 1972
Education: MSc, MBA, PhD Medical Biochemistry and Biophysics
Shares in Genovis: none

Other Directorship

Magnus Gustafsson has no other board assignments.

Relevant Work Experience

Currently employed as Chief Business Officer at Biovian a Nordic CDMO. He has more than 15 years of experience from different commercial positions such as and Head of Global Business Development at Biovian, Director Strategy; Search and Evaluation at Cytiva/GE Healthcare Life Sciences and as Corporate and Business Development Director at Cobra Biologics (now Charles River).

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: May 12, 2022

  • Svenska